Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 44, Issue 7 (Jul 2006)

Issues

Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease

Benjamin Dieplinger / Werner Poelz / Meinhard Haltmayer
  • Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz, Linz, Austria and Paracelsus Private Medical University, Salzburg, Austria
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Thomas Mueller
Published Online: 2006-06-16 | DOI: https://doi.org/10.1515/CCLM.2006.145

Abstract

There is growing evidence that adiponectin, an adipocytokine with anti-inflammatory and antiathero-genic properties, is involved in the development of atherosclerosis. The aim of the present study was to examine whether serum levels of adiponectin were associated with symptomatic atherosclerotic peripheral arterial disease (PAD). Serum concentrations of adiponectin were measured in 433 patients with symptomatic PAD and 433 controls from the Linz Peripheral Arterial Disease (LIPAD) study. Cases and controls were matched for age, sex and diabetes mellitus. The median serum level of adiponectin was significantly lower in PAD patients than in control subjects (9.5 vs. 10.8mg/L; p=0.014). After adjustment for several possible confounding variables using multivariable logistic regression, odds ratios for symptomatic PAD were 0.95 (95% CI, 0.64–1.42; p=0.080) and 0.59 (95% CI, 0.36–0.97; p=0.037) in the second and third tertiles for adiponectin serum concentrations, respectively, compared with the first tertile. Low serum levels of adiponectin were associated with the presence of symptomatic atherosclerotic PAD, independent of traditional and non-traditional risk factors, suggesting that hypoadiponectinemia may be a marker for systemic atherosclerotic disease.

Clin Chem Lab Med 2006;44:830–3.

Keywords: adiponectin; atherosclerosis; peripheral vascular disease; risk factors

References

  • 1.

    Matsuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005; 6:7–14.CrossrefGoogle Scholar

  • 2.

    Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004; 344:1–12.Google Scholar

  • 3.

    Iwashima Y, Horio T, Suzuki Y, Kihara S, Rakugi H, Kangawa K, et al. Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 2005 Nov 28; Epub ahead of print (doi:10.1016/j.atherosclerosis.2005.10.039).CrossrefGoogle Scholar

  • 4.

    Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163:884–92.Google Scholar

  • 5.

    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg 2005; 41:808–15.Google Scholar

  • 6.

    Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26:517–38.Google Scholar

  • 7.

    Clinical and Laboratory Standards Institute. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS document EP5-A. Wayne, PA: CLSI, 1999.Google Scholar

  • 8.

    Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 2005; 45:1094–100.Google Scholar

About the article

Corresponding author: Thomas Mueller, Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Seilerstaette 2-4, 4020 Linz, Austria Phone: +43-732-76773621, Fax: +43-732-76773799,


Received: 2006-01-30

Accepted: 2006-03-10

Published Online: 2006-06-16

Published in Print: 2006-07-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.145.

Export Citation

©2006 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Thomas Mueller, Franz Hinterreiter, Christian Luft, Werner Poelz, Meinhard Haltmayer, and Benjamin Dieplinger
Journal of Vascular Surgery, 2014, Volume 59, Number 5, Page 1291
[2]
Claudia D. Gherman, Doru Pamfil, and Sorana D. Bolboacă
BioMed Research International, 2013, Volume 2013, Page 1
[3]
Claudia D. Gherman and Aurel I. Mironiuc
Mediators of Inflammation, 2012, Volume 2012, Page 1
[4]
Benjamin Dieplinger, Werner Poelz, Meinhard Haltmayer, and Thomas Mueller
Clinica Chimica Acta, 2007, Volume 377, Number 1-2, Page 192
[5]
[6]
Grazina Urbonaviciene, Jan Frystyk, Allan Flyvbjerg, Eskild W. Henneberg, and Jes S. Lindholt
Atherosclerosis, 2010, Volume 210, Number 2, Page 619
[7]
José Luis Zamorano and Alexandra Gonçalves
Cardiology, 2011, Volume 118, Number 4, Page 248
[8]
C. Antoniades, A. S. Antonopoulos, D. Tousoulis, and C. Stefanadis
Obesity Reviews, 2009, Volume 10, Number 3, Page 269
[9]
PAIK-SEONG LIM, CHUEN-YUH HU, MING-YING WU, TSAI-KUN WU, and HUI-CHEN CHANG
Nephrology, 2007, Volume 12, Number 6, Page 546

Comments (0)

Please log in or register to comment.
Log in